In CD8+ T cells, the percentages of naïve T cells and central memory T cells were higher in IFN-β-treated MS patients than in untreated MS patients (padj = 0.031 and 0.013, respectively, Additional file 1: Table S5). This evidence concerns the gene IFNB1 and myeloid sarcoma.